XML 63 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial expenses-net (Tables)
 12 Months Ended
Dec. 31, 2021
Schedule of Financial Expenses
    
Year ended December, 31
  
    
  2021  
     
  2020  
     
  2019  
  
    
(U.S. $ in millions)
  
Interest expenses and other bank charges
      891        901        822  
(Income) loss from investments (1)
      90        (104 )       (41 ) 
Foreign exchange (gains) losses, net
      7        (26 )       (15 ) 
Other, net (2)
      71        62        55  
    
 
 
     
 
 
     
 
 
  
Total finance expense, net
    $ 1,058      $ 834      $ 822  
    
 
 
     
 
 
     
 
 
  
 
(1)
(Income) loss from investments in 2021 and 2020 comprised mainly of revaluation gains and loss of Teva’s investment in American Well Corporation (“American Well”). See note 20.
(2)
Amortization of issuance costs and terminated derivative instruments.